Start typing to retrieve search suggestions. When suggestions are available use up and down arrows to review and ENTER to select. Continue typing to refine.
Advanced search

Report side effect

Report a suspected side effect or falsified product to the MHRA Yellow Card scheme.
Go to {yellow_card_logo} site
Trusted Information Creator
Certified November 2025
{arrow_up} Back to top

Treposuvi 2.5 mg/ml solution for infusion

Active Ingredient:
treprostinil sodium
Company:  
AOP Orphan Ltd See contact details
ATC code: 
B01AC21
{info_black}
About Medicine
{medical_services}
Prescription only medicine
Healthcare Professionals (SmPC) Patient Leaflet (PIL) Risk Materials
{arrow_left}
{arrow_right}

Educational Risk Minimisation Materials to help reduce the risk associated with using this medicine.

{pdf_link}

Treposuvi Solution for Infusion - Healthcare Professional Guide

This guide details the risk of central venous catheter related blood stream infections and sepsis associated with the intravenous route of administration of Treprosuvi Solution For Infusion
{pdf_link}

Treposuvi Solution for Infusion - Patient Brochure

This guide details the risk of central venous catheter related blood stream infections and sepsis associated with the intravenous route of administration of Treposuvi Solution For Infusion
{pdf_link}

Treposuvi Solution for Infusion - Patient Questionnaire

A questionnaire for patients treated with intravenous Treposuvi via an external infusion pump and central venous catheter (CVC)

You are trying to reach document intended for healthcare professionals only.

Are you a healthcare professional?

Log in or sign up to avoid further verifications.

AOP Orphan Ltd
Company image
Address
Colmore Plaza, 20 Colmore Circus Queensway, Birmingham, West Midlands, B4 6AT, UK
Telephone
+44 (0) 121 262 4119
Fax
+44 (0) 121 566 9010
Medical Information e-mail
[email protected]
WWW
http://www.aoporphan.co.uk
E-mail
[email protected]